Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2015-05-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DAILIES TOTAL1® - Comparative Assessment of Tear Film Evaporation
NCT02517567
Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses
NCT01561560
Pre-Lens Tear Film Performance of Silicone Hydrogel Daily Disposable Contact Lenses
NCT01548833
Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear
NCT03560141
Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses
NCT01634659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TruEye, MyDay, clariti 1day
Narafilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3. Each product worn bilaterally (in both eyes) for 1 day (16 hours).
Narafilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Stenfilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Somofilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
TruEye, clariti 1day, MyDay
Narafilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).
Narafilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Stenfilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Somofilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
MyDay, TruEye, clariti 1day
Stenfilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).
Narafilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Stenfilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Somofilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
MyDay, clariti 1day, TruEye
Stenfilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).
Narafilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Stenfilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Somofilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Clariti 1day, TruEye, MyDay
Somofilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).
Narafilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Stenfilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Somofilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Clariti 1day, MyDay, TruEye
Somofilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).
Narafilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Stenfilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Somofilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Narafilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Stenfilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Somofilcon A contact lenses
Silicone hydrogel contact lenses for daily disposable wear
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Soft contact lens wearer (both eyes).
* Willing to wear study lenses at least 16 waking hours and attend all study visits.
Exclusion Criteria
* Use of systemic or ocular medications for which contact lens wear could be contraindicated.
* Use of artificial tears and rewetting drops during the study.
* Monocular (only 1 eye with functional vision) or fit with only 1 lens.
* History of herpetic keratitis, ocular surgery, or irregular cornea.
* Pregnant.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Manager, Vision Care, Global Medical Affairs
Role: STUDY_DIRECTOR
Alcon Research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLT567-P001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.